AU2001275809A1 - Anti-angiogenic composition comprising ticlopidine and ginkgo biloba extract - Google Patents

Anti-angiogenic composition comprising ticlopidine and ginkgo biloba extract

Info

Publication number
AU2001275809A1
AU2001275809A1 AU2001275809A AU7580901A AU2001275809A1 AU 2001275809 A1 AU2001275809 A1 AU 2001275809A1 AU 2001275809 A AU2001275809 A AU 2001275809A AU 7580901 A AU7580901 A AU 7580901A AU 2001275809 A1 AU2001275809 A1 AU 2001275809A1
Authority
AU
Australia
Prior art keywords
ticlopidine
ginkgo biloba
biloba extract
angiogenic composition
angiogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275809A
Inventor
Min Young Kim
Chang Hee Moon
Byung Young Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiolab Inc
Original Assignee
Angiolab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiolab Inc filed Critical Angiolab Inc
Publication of AU2001275809A1 publication Critical patent/AU2001275809A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001275809A 2000-07-28 2001-07-27 Anti-angiogenic composition comprising ticlopidine and ginkgo biloba extract Abandoned AU2001275809A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR0043589 2000-07-28
KR1020000043589A KR20020010230A (en) 2000-07-28 2000-07-28 Use of 5-[(2-chlorophenyl) methyl]-4,5,6,7-tetrahydrothieno [3,2-c] pyridine or hydrochloride thereof, ticlopidine, as an inhibitor of angiogenesis
PCT/KR2001/001280 WO2002009708A1 (en) 2000-07-28 2001-07-27 Anti-angiogenic composition comprising ticlopidine and ginkgo biloba extract

Publications (1)

Publication Number Publication Date
AU2001275809A1 true AU2001275809A1 (en) 2002-02-13

Family

ID=19680472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275809A Abandoned AU2001275809A1 (en) 2000-07-28 2001-07-27 Anti-angiogenic composition comprising ticlopidine and ginkgo biloba extract

Country Status (3)

Country Link
KR (1) KR20020010230A (en)
AU (1) AU2001275809A1 (en)
WO (1) WO2002009708A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100455531B1 (en) * 2001-11-13 2004-11-15 배선량 The compositon for corneal angiogenesis inhibition with ticlopidine, and the producing method of therof
DE50211883D1 (en) * 2002-04-30 2008-04-24 Cognis Ip Man Gmbh Use of active substance mixtures with azelaic acid and glycyrrhetinic acid as anti-acne agents
CN110195037A (en) * 2019-05-29 2019-09-03 西安交通大学 A kind of human umblilical vein endothelial primary separation and culture method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021177A4 (en) * 1997-02-04 2002-05-15 John V Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
KR100258018B1 (en) * 1997-12-23 2000-07-01 유승필 A pharmaceutical composition comprising ticlopidine and ginkgo extract

Also Published As

Publication number Publication date
WO2002009708A1 (en) 2002-02-07
KR20020010230A (en) 2002-02-04

Similar Documents

Publication Publication Date Title
PL354315A1 (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
GB2352177B (en) Composition from ginkgo biloba leaves preparation and uses
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0300409A3 (en) Pharmaceutical compositions containing antiadhesive carbohydrates and their use
AU2001294814A1 (en) Pumpcn compositions and uses thereof
HK1063461A1 (en) Ketone compounds and compositions for cholesterolhmanagement and related uses
PL357713A1 (en) Caspase inhibitors and uses thereof
EP1311551A4 (en) Bioactive coating compositions and methods
HUP0302455A3 (en) Combination pharmaceutical compositions containing amplodipine and benazepril and their use
EG23005A (en) Deodorant and/or antiperspirant compositions
IL152094A0 (en) Ecteinascidin derivatives and pharmaceutical compositions containing the same
IL152846A0 (en) Pyridazinone derivatives and pharmaceutical compositions containing the same
IL137363A0 (en) Pharmaceutical compositions containing mupirocin
AU2002220419A1 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
SG100745A1 (en) Ceramic composition and ceramic capacitor
GB0027391D0 (en) Films and compositions
AU2001267382A1 (en) Antiperspirant and/or deodorant compositions
AU2001275809A1 (en) Anti-angiogenic composition comprising ticlopidine and ginkgo biloba extract
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
AU2001277786A1 (en) Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
GB0013503D0 (en) Pharmaceutical compositions and their uses
IL162112A0 (en) Mint extract and related pharmaceutical compositions
EP1402892A4 (en) Antiinflammatoric and antitussive compositions
AU2001263904A1 (en) Antiperspirant and/or deodorant compositions